ELAVL3 (HuC) is a neuron-specific RNA-binding protein with three RNA recognition motifs (RRMs) and a hinge/linker region that binds to AU-/U-rich elements in the 3'-UTRs of target mRNAs to regulate mRNA stability, alternative splicing, alternative polyadenylation (3'-UTR length choice), and transcript abundance. RRM1 and RRM2 directly associate with AU-rich RNA, while RRM3 promotes transcript stability via poly(A)-tail-associated mechanisms. ELAVL3 is predominantly cytoplasmic but shuttles between nucleus and cytoplasm via signals in the hinge region. It plays essential roles in neuronal differentiation, maintenance, and synaptic integrity, particularly in the cerebellum and hippocampus; ELAVL3 loss perturbs splicing programs converging on glutamate regulation and neuronal excitability (e.g., AnkG exon 34 mis-inclusion), producing seizures and cerebellar ataxia in knockout models.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0140517
protein-RNA adaptor activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for protein-RNA adaptor activity based on phylogenetic inference. ELAVL3 functions as an RNA-binding protein that binds AU-rich elements in 3'-UTRs and regulates mRNA stability and processing, consistent with adaptor activity.
Reason: This term accurately captures ELAVL3's core molecular function as a protein that mediates interactions between RNA molecules and other cellular components through its RNA-binding activity. The deep research confirms ELAVL3 "binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs" and "regulates alternative splicing, mRNA stability, and transcript abundance". UniProt confirms it "binds to AU-rich element (ARE) sequences of target mRNAs" [PMID:10710437]. IBA annotations are typically well-curated and phylogenetically sound.
Supporting Evidence:
PMID:10710437
HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs. This binding regulates alternative splicing, mRNA stability, and transcript abundance
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 functions primarily as a post-transcriptional regulator that stabilizes target transcripts, in part by binding AU-rich elements and influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize on RNA and oppose destabilizing factors.
PMID:37697079
Binding to RNA targets is facilitated by the RRM1 and RRM2 domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
|
|
GO:0003676
nucleic acid binding
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: IEA annotation for nucleic acid binding based on InterPro domain assignment. This is a very general parent term for RNA binding.
Reason: While technically correct (ELAVL3 does bind nucleic acids), this term is too broad and uninformative. ELAVL3 specifically binds RNA, not DNA, through its three RRM domains. The more specific term GO:0003723 (RNA binding) is already annotated and better represents the actual molecular function.
Proposed replacements:
RNA binding
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 contains three RNP-type RNA recognition motifs (RRMs), which are responsible for its RNA-binding activity
|
|
GO:0003723
RNA binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for RNA binding from combined automated annotation methods. This is appropriate but less specific than the available AU-rich region binding terms.
Reason: This term accurately describes ELAVL3's core molecular function. ELAVL3 contains three RRM domains that bind RNA, specifically to AU-rich and GU-rich sequences in mRNA 3'-UTRs. While more specific terms exist (mRNA 3'-UTR AU-rich region binding), this general RNA binding term is acceptable and correct as a broader classification.
Supporting Evidence:
PMID:10710437
These proteins bind to AU-rich elements in the 3'-untranslated regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 contains three RNP-type RNA recognition motifs (RRMs), which are responsible for its RNA-binding activity
PMID:37697079
All four ELAVL proteins share a common basic structure, of three RNA recognition motif (RRM) binding domains and a hinge region
|
|
GO:0003730
mRNA 3'-UTR binding
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation for mRNA 3'-UTR binding from ARBA machine learning models. This accurately captures ELAVL3's specific binding preference for 3'-UTR regions.
Reason: This is a highly specific and accurate molecular function term for ELAVL3. Multiple lines of evidence demonstrate that ELAVL3 preferentially binds to AU-rich elements located in the 3'-UTRs of target mRNAs including VEGF and c-myc. This is a core molecular function of the protein.
Supporting Evidence:
PMID:10710437
HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
|
|
GO:0007399
nervous system development
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation for nervous system development based on UniProtKB keyword mapping. ELAVL3 is neuron-specific and plays roles in neuronal differentiation and maintenance.
Reason: This biological process term is well-supported. ELAVL3 is brain-specific and essential for neurogenesis, neuronal differentiation, and maintenance of neurons. The deep research indicates ELAVL3 is "involved in the development and maintenance of neurons" and knockout mice exhibit severe motor deficits and cerebellar ataxia. UniProt states it "may be involved in neuronal differentiation and maintenance".
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Neurogenesis: ELAVL3 is involved in the development and maintenance of neurons
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 knockout mice exhibit progressive motor deficits, severe cerebellar ataxia, and Purkinje cell axonal degeneration
PMID:37697079
As Elavl3β/β mice aged, progressive severe cerebellar ataxia was observed
PMID:37697079
At the cellular level, Purkinje neurons had disrupted synaptic formation, swollen axons, and overall deficits in neuronal transport, highlighting the requirement for Elavl3 activity in these neurons
|
|
GO:0030154
cell differentiation
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: IEA annotation for cell differentiation based on UniProtKB keyword mapping. This is a very general process term that applies to ELAVL3's role in neuronal differentiation.
Reason: While technically correct (ELAVL3 is involved in neuronal differentiation), this term is too broad and non-specific. The more precise term would be neuronal differentiation or neuron differentiation, which better captures ELAVL3's tissue-specific role. Given that ELAVL3 is brain-specific and specifically involved in neurogenesis, a more specific term should be used.
Proposed replacements:
neuron differentiation
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Neurogenesis: ELAVL3 is involved in the development and maintenance of neurons
PMID:37697079
Elavl3 expression is upregulated during the differentiation of neural stem cells into inhibitory GABAergic neurons, in parallel with 3βUTR lengthening. Depletion of Elavl3 during this differentiation process caused a shift towards using proximal polyA sites compared to control cells, with a concomitant delay in neural stem cell differentiation
|
|
GO:1990904
ribonucleoprotein complex
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation for ribonucleoprotein complex based on InterPro domain assignment. This cellular component term reflects ELAVL3's association with RNA as an RNP complex component.
Reason: This is an appropriate cellular component annotation. ELAVL3 is an RNA-binding protein with RRM domains that forms ribonucleoprotein complexes with its target mRNAs. The deep research notes ELAVL3 binds over 1,100 transcripts in certain contexts, indicating it forms functional RNP complexes. While more specific localization terms could be added (nucleus, cytoplasm), this general RNP complex annotation is correct.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
In neuroendocrine cancer cell lines, ELAVL3 binds over 1,100 transcripts, with enrichment for genes involved in neuron projection development and synapse organization
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is predominantly localized in the nucleus and cytoplasm of neurons throughout the brain
|
|
GO:0035925
mRNA 3'-UTR AU-rich region binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation for mRNA 3'-UTR AU-rich region binding from Ensembl Compara orthology transfer. This is the most specific and accurate molecular function term for ELAVL3.
Reason: This is the most precise molecular function annotation for ELAVL3 and represents its core biochemical activity. ELAVL3 specifically binds to AU-rich elements (AREs) in the 3'-UTRs of target mRNAs. PMID:10710437 experimentally demonstrates HuC binding to AU-rich regions in VEGF and c-myc 3'-UTRs. The deep research confirms binding to "GU-rich and AU-rich sequences" in 3'-UTRs. This annotation captures the key sequence specificity that distinguishes ELAVL3 from general RNA-binding proteins.
Supporting Evidence:
PMID:10710437
These proteins bind to AU-rich elements in the 3'-untranslated regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
|
|
GO:0005515
protein binding
|
IPI
PMID:36950384 Protein interaction studies in human induced neurons indicat... |
REMOVE |
Summary: IPI annotation for protein binding based on physical interaction evidence from a large-scale proteomics study on autism spectrum disorders.
Reason: While ELAVL3 does interact with proteins (UniProt mentions MAP1B light chain LC1, and IntAct shows interactions with DYRK1A, SCN2A, SYNGAP1), the generic "protein binding" term is uninformative and does not describe a molecular function. This term should not be used unless referring to a specific functional role (e.g., as an adapter or scaffold). The reference PMID:36950384 is a large-scale protein interaction study where ELAVL3 may have been detected as an interactor, but this does not constitute evidence for "protein binding" as a molecular function. ELAVL3's primary molecular function is RNA binding, not protein binding.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Molecular Function: ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
PMID:36950384
eCollection 2023 Mar 8.
|
|
GO:0005515
protein binding
|
IPI
PMID:37207277 Using brain cell-type-specific protein interactomes to inter... |
REMOVE |
Summary: IPI annotation for protein binding based on physical interaction evidence from a large-scale brain cell-type-specific protein interactome study on schizophrenia.
Reason: Same rationale as for PMID:36950384. The generic "protein binding" term is uninformative and should be avoided in GO curation. While ELAVL3 does engage in protein-protein interactions, this is not its primary molecular function, and the term does not provide useful functional information. ELAVL3 is fundamentally an RNA-binding protein. Large-scale proteomics studies detect many interactions, but these do not necessarily represent the core molecular function of the protein.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Molecular Function: ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
PMID:37207277
eCollection 2023 May 19.
|
|
GO:0035925
mRNA 3'-UTR AU-rich region binding
|
IDA
PMID:10710437 RNA-binding analyses of HuC and HuD with the VEGF and c-myc ... |
ACCEPT |
Summary: IDA annotation for mRNA 3'-UTR AU-rich region binding based on direct experimental evidence from PMID:10710437. This is a duplicate of the IEA annotation but with stronger experimental evidence.
Reason: This is the gold standard annotation for ELAVL3 - direct experimental evidence (IDA) for its most specific and important molecular function. PMID:10710437 directly demonstrates using an ELISA-based assay that HuC (ELAVL3) binds to AU-rich elements in the 3'-UTRs of VEGF and c-myc mRNAs in a specific and concentration-dependent manner. This represents the core biochemical activity of ELAVL3. The experimental evidence is robust and the term is maximally informative.
Supporting Evidence:
PMID:10710437
I demonstrate that HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
PMID:10710437
These proteins bind to AU-rich elements in the 3'-untranslated regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
|
|
GO:0005634
nucleus
|
NAS | NEW |
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. ELAVL3 has a smaller nuclear pool that supports roles in splicing and APA, consistent with nucleocytoplasmic shuttling driven by hinge-region signals.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
UniProtKB:Q14576
May be involved in neuronal differentiation and maintenance (By similarity).
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic shuttling. A smaller nuclear pool supports roles in splicing and RNA processing, while the hinge/linker region contributes to export/localization control.
PMID:37697079
Nuclear export and localisation signals located in the hinge region of the ELAVL proteins are responsible for the shuttling of RNAs between the nucleus and cytoplasm
|
|
GO:0005737
cytoplasm
|
NAS | NEW |
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. nELAVL proteins including ELAVL3 are predominantly cytoplasmic where they participate in cytoplasmic mRNA stability and translation control.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
UniProtKB:Q14576
May be involved in neuronal differentiation and maintenance (By similarity).
PMID:37697079
nELAVL proteins are primarily cytoplasmic, with a small fraction of nuclear activity, reflecting their roles (for example nuclear export, subcellular shuttling)
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic shuttling.
|
|
GO:0010608
post-transcriptional regulation of gene expression
|
NAS | NEW |
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. Falcon-cited literature reinforces ELAVL3's role as a post-transcriptional regulator controlling splicing, APA/3'-UTR length choice, mRNA stability and translation.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
UniProtKB:Q14576
May be involved in neuronal differentiation and maintenance (By similarity).
PMID:37697079
RNA-binding proteins (RBPs) are recognised as key regulators of post-transcriptional gene regulation, where their binding controls splicing, polyadenylation, nuclear export, mRNA stability and translation rate and decay
|
|
GO:0000380
alternative mRNA splicing, via spliceosome
|
NAS | NEW |
Summary: Added based on falcon-cited literature documenting ELAVL3 regulation of neuronal alternative splicing programs.
Reason: Falcon and Mulligan 2023 (PMID:37697079) document that ELAVL3 regulates alternative splicing of neuronal transcripts (e.g., AnkG/ANK3 exon 34) with convergence on glutamate-regulation and excitability pathways. This is a core molecular process not previously captured in existing_annotations.
Supporting Evidence:
PMID:37697079
Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific exon 34 in the AnkG transcript.
PMID:37697079
High-throughput sequencing analysis of alternative splicing in the cerebellum of Elavl3β/β mice highlighted the convergence of targeted transcripts on glutamate levels and neuronal excitability
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 has a documented role in alternative splicing; all three RRMs plus the hinge region contribute to HuC-dependent splice regulation, and ELAVL3 loss alters neuronal splicing programs linked to excitability.
|
|
GO:0110104
mRNA alternative polyadenylation
|
NAS | NEW |
Summary: Added based on falcon-cited literature documenting ELAVL3 regulation of alternative polyadenylation and 3'-UTR length choice in neurons.
Reason: Multiple sources cited by falcon (Mulligan 2023 PMID:37697079; Dorrity 2023 PMID:37862432) demonstrate that ELAVL3 (with other nELAVLs) promotes neuronal 3'-UTR lengthening through distal poly(A) site usage; ELAVL3 depletion shifts usage toward proximal sites. This is a distinct molecular process from splicing/stability and warrants a separate annotation.
Supporting Evidence:
PMID:37697079
Depletion of Elavl3 during this differentiation process caused a shift towards using proximal polyA sites compared to control cells, with a concomitant delay in neural stem cell differentiation
PMID:37862432
the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 participates in regulation of alternative polyadenylation and 3β²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β²UTRs.
|
|
GO:0003729
mRNA binding
|
NAS | NEW |
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. ELAVL3 binds mRNA via three RRM domains; this captures the molecular function used to regulate splicing/APA/stability of target mRNAs.
Supporting Evidence:
PMID:37697079
All four ELAVL proteins share a common basic structure, of three RNA recognition motif (RRM) binding domains and a hinge region
PMID:37697079
Binding to RNA targets is facilitated by the RRM1 and RRM2 domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target of this report is human ELAVL3 (UniProt Q14576), encoding ELAV-like protein 3, historically named HuC, a neuron-enriched member of the neuronal ELAVL (nELAVL) RNA-binding protein family (ELAVL2/HuB, ELAVL3/HuC, ELAVL4/HuD), distinct from the ubiquitously expressed ELAVL1/HuR. This identity mapping (ELAVL3βHuC) is explicitly stated in a recent authoritative genetics review of nELAVLs. (mulligan2023themoleculargenetics pages 1-2, mulligan2023themoleculargenetics pages 2-4)
| Property | Summary for ELAVL3 (HuC; UniProt Q14576) | Supporting citations |
|---|---|---|
| Approved gene / protein name | ELAVL3 encodes ELAV-like protein 3, a neuronal RNA-binding protein in human. Historical name HuC is explicitly mapped to ELAVL3 in review literature. | (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2) |
| Synonyms / aliases | Common aliases include HuC; the UniProt-provided aliases for this target are HUC and PLE21. Literature in the retrieved evidence directly confirms the HuC name for ELAVL3. | (mulligan2023themoleculargenetics pages 1-2) |
| Organism / target identity | The reviewed literature matches the intended target: human ELAVL3/HuC, a neuronal ELAVL-family RNA-binding protein, with no conflicting gene identity found in the evidence set. | (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2) |
| Family membership | ELAVL3 belongs to the neuronal ELAVL (nELAVL) subgroup together with ELAVL2/HuB and ELAVL4/HuD; ELAVL1/HuR is the ubiquitous family member. nELAVLs are enriched in the nervous system. | (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2, negeri2024theroleof pages 39-45, medici2026targetingtherna pages 8-12) |
| Domain architecture | ELAVL3 shares the canonical ELAVL architecture of three RNA recognition motifs (RRM1, RRM2, RRM3) plus a hinge/linker region between RRM2 and RRM3. The hinge contributes to protein interactions and nucleocytoplasmic trafficking. | (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 7-8, costantino2024elavl3disruptionina pages 22-26, costantino2024elavl3disruptionin pages 22-26) |
| RNA-binding specificity | ELAVL proteins, including ELAVL3, preferentially bind AU-/U-rich elements in target RNAs, especially in 3β²UTRs. RRM1/2 mediate direct binding to AU-rich RNA, whereas RRM3 contributes to poly(A)-tail binding and transcript stabilization. | (medici2026targetingtherna pages 8-12, mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 7-8, costantino2024elavl3disruptionina pages 22-26) |
| Core molecular function: mRNA stability | ELAVL3 functions primarily as a post-transcriptional regulator that stabilizes target transcripts, in part by binding AU-rich elements and influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize on RNA and oppose destabilizing factors. | (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, costantino2024elavl3disruptionina pages 22-26) |
| Core molecular function: translation | ELAVL-family proteins regulate translation as part of ribonucleoprotein complexes that route RNAs toward translation or decay; RRM3/poly(A)-associated functions connect ELAVL3 to translational control. | (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, costantino2024elavl3disruptionina pages 22-26) |
| Core molecular function: alternative splicing | ELAVL3 has a documented role in alternative splicing; all three RRMs plus the hinge region contribute to HuC-dependent splice regulation, and ELAVL3 loss alters neuronal splicing programs linked to excitability. | (mulligan2023themoleculargenetics pages 7-8, mulligan2023themoleculargenetics pages 6-7, costantino2024elavl3disruptionin pages 22-26) |
| Core molecular function: alternative polyadenylation / 3β²UTR length | ELAVL3 participates in regulation of alternative polyadenylation and 3β²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β²UTRs. | (mulligan2023themoleculargenetics pages 6-7, dorrity2023long3β²utrspredispose pages 8-9) |
| Biological role emphasis | Current understanding places ELAVL3 as a key neuronal post-transcriptional regulator affecting transcript isoform choice, mRNA stability, neuronal differentiation, glutamate-related pathways, and neuronal excitability. | (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 6-7, wutikeli2025elavhurnabindingprotein pages 6-7) |
| Typical subcellular localization | ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic shuttling. A smaller nuclear pool supports roles in splicing and RNA processing, while the hinge/linker region contributes to export/localization control. | (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 4-5, costantino2024elavl3disruptionin pages 22-26) |
Table: This table summarizes the verified identity, family context, domain organization, RNA-binding specificity, molecular functions, and localization of human ELAVL3/HuC. It is useful as a concise reference for functional annotation grounded in the retrieved evidence.
ELAVL3 is best understood as a post-transcriptional regulator that binds mRNAs to control their processing and fate, including alternative splicing, alternative polyadenylation (APA)/3β²UTR length choice, mRNA stability/decay, mRNA transport, and translation. This βmulti-layerβ control is a canonical feature of ELAVL family RBPs in neuronal programs. (mulligan2023themoleculargenetics pages 2-4, negeri2024theroleof pages 39-45)
Across ELAVL proteins, a conserved architecture of three RNA recognition motifs (RRM1βRRM3) plus a hinge/linker region supports RNA binding and nucleo-cytoplasmic dynamics. Mechanistically, RRM1/2 primarily mediate binding to AU-/U-rich elements commonly found in 3β²UTRs, while RRM3 contributes to binding at/near the poly(A) tail and transcript stabilization; ELAVL proteins can also multimerize on RNA in an RNA-dependent manner to enhance binding. HuCβs three RRMs and hinge region have distinct roles in alternative splicing regulation, indicating domain specialization within this architecture. (mulligan2023themoleculargenetics pages 2-4, medici2026targetingtherna pages 8-12, costantino2024elavl3disruptionina pages 22-26, mulligan2023themoleculargenetics pages 7-8)
nELAVLs (including ELAVL3) are described as predominantly cytoplasmic while retaining the ability to shuttle between nucleus and cytoplasm, consistent with combined functions in nuclear pre-mRNA processing (e.g., splicing/APA decisions) and cytoplasmic control of mRNA stability/translation. (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, costantino2024elavl3disruptionin pages 22-26)
| Publication | Date | Venue | URL / DOI | Study type | Key ELAVL3/HuC findings | Quantitative data | Supporting citations |
|---|---|---|---|---|---|---|---|
| Mulligan, 2023 | Sep 2023 | European Journal of Human Genetics | https://doi.org/10.1038/s41431-023-01456-z | Review; human/mouse/genetics | Authoritative review confirming human ELAVL3 = HuC; neuronal ELAVL family member with 3 RRMs + hinge; regulates mRNA stability, translation, alternative splicing, and alternative polyadenylation/3β²UTR length; ELAVL3 loss linked to altered glutamate-regulatory transcripts, neuronal excitability, delayed GABAergic differentiation, seizures, and cerebellar ataxia. Also summarizes ALS-linked nuclear depletion/downregulation and proposes biomarker relevance. | Notes ELAVL3-dependent AnkG exon 34 mis-splicing at 2 and 9 months in knockout mice; cites large human genetics datasets including >16,000 ASD GWAS individuals, 2,104 ID trios, and 42,607 autism cases in broader ELAVL-family analyses. | (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2, mulligan2023themoleculargenetics pages 6-7, mulligan2023themoleculargenetics pages 7-8, mulligan2023themoleculargenetics pages 5-6) |
| Dorrity, 2023 | Oct 2023 | Science Immunology | https://doi.org/10.1126/sciimmunol.adg2979 | Primary; human stem cell-derived neurons and cell systems | Shows neuron-enriched ELAVL proteins (ELAVL2/3/4) promote neuronal 3β²UTR lengthening, increasing dsRNA load and tonic activation of dsRNA sensors (MDA5, PKR, TLR3). HuC is implicated in a neuron-specific post-transcriptional program that couples long 3β²UTRs to antiviral immunity and inflammatory risk. Combined HuB/C/D expression caused global 3β²UTR lengthening without major bulk transcript-level changes. | Reports that more than half of human genes have alternative 3β²UTRs; human developmental atlas integrated 393,060 single cells is cited elsewhere as context for developmental expression; ADAR1 KO neurons died by day 25 after differentiation in this study. | (dorrity2023long3β²utrspredispose pages 8-9) |
| OβDonovan, 2020 | Jul 2020 | Brain Communications | https://doi.org/10.1093/braincomms/fcaa059 | Primary; human serum/CSF, paraneoplastic neurology | Closest highly relevant clinical paper for anti-Hu autoimmunity. Anti-Hu antibodies target the neuronal ELAVL family including ELAVL3/HuC, but dominant mapped reactivity centered on a shared nELAVL epitope motif rather than uniquely on ELAVL3. High-resolution PhIP-Seq/mutational scanning identified an immunodominant RLDxLL motif and a focused 17-residue signature near the ELAVL hinge region, supporting diagnostic epitope mapping applications. | Cohorts: 44 anti-Hu patients and 36 anti-Yo patients; 38% of anti-Hu patients enriched nELAVL peptides; 76 total anti-Hu samples (32 paired serum/CSF, 2 CSF, 10 serum); 19 samples with significant nELAVL enrichment; 20 unique nELAVL peptides; >80% of enriched peptides mapped to ELAVL4; 0/50 healthy control sera showed significant nELAVL enrichment; 34/36 (94%) peptides in motif reanalysis shared RLDxxLL. | (oβdonovan2020highresolutionepitopemapping pages 2-3, oβdonovan2020highresolutionepitopemapping pages 13-13, oβdonovan2020highresolutionepitopemapping pages 10-10, oβdonovan2020highresolutionepitopemapping pages 1-2, oβdonovan2020highresolutionepitopemapping pages 13-14, oβdonovan2020highresolutionepitopemapping pages 12-13, oβdonovan2020highresolutionepitopemapping media bbad15e1, oβdonovan2020highresolutionepitopemapping media f77dc5fb) |
| Kim, 2024 | Oct 2024 | Experimental & Molecular Medicine | https://doi.org/10.1038/s12276-024-01328-6 | Primary; human single-cell atlas / developmental expression | Integrative single-cell atlas of developing human brain includes ELAVL3 among disorder-related genes with temporally patterned neuronal expression, supporting its role as a neuronal lineage/development marker and neurodevelopmental risk-associated gene. | Atlas integrates 393,060 single cells across developmental stages. | (dorrity2023long3β²utrspredispose pages 8-9) |
| Costantino, 2024 | 2024 | Dissertation / neuropathology study | DOI not clearly resolved in evidence excerpt | Primary; human postmortem ALS/FTLD tissue | Focused 2024 human neuropathology study of ELAVL3 disruption in ALS/FTLD. Reports cryptic mis-splicing of ELAVL3 transcripts, nuclear depletion of ELAVL3 protein, cytoplasmic granular pathology, and ELAVL3-positive threadlike processes. Reduced nuclear ELAVL3 associates with pTDP-43 or tau pathology, suggesting shared RNA-binding protein dysfunction across neurodegenerative proteinopathies. | In prior anterior horn motor neurons, nearly 75% showed total loss of nuclear ELAVL3; in FTLD-Tau, 4/5 cases showed related ELAVL3 nuclear loss in cells with phosphorylated aggregates. | (costantino2024elavl3disruptioninb pages 107-112, costantino2024elavl3disruptionina pages 107-112, costantino2024elavl3disruptionina pages 1-7) |
| Moakley, 2024 | Jun 2024 | bioRxiv | https://doi.org/10.1101/2024.06.13.597128 | Primary preprint; mouse single-cell/splicing network | Reverse-engineering study of neuron type-specific splicing networks identifies Elavl3/HuC as broadly expressed among neuronal classes and part of splicing-regulatory programs shaping neuronal identity. Useful for pathway context, though not an ELAVL3-focused mechanistic paper. | Derived networks from 133 mouse neocortical cell types defined by single-cell transcriptomes and inferred regulons for 350 RBPs. | (OpenTargets Search: -ELAVL3) |
| Lee, 2023 | Oct 2023 | Life Science Alliance | https://doi.org/10.26508/lsa.202302000 | Review; neuronal RNA processing | Broad review of neuronal alternative splicing and polyadenylation that provides pathway context for nELAVL proteins, including ELAVL3, as regulators of neural-specific isoform processing and 3β²UTR biology. | No ELAVL3-specific quantitative value extracted from available excerpt. | (OpenTargets Search: -ELAVL3) |
| Lee, 2024 | Jun 2024 | Experimental & Molecular Medicine | https://doi.org/10.1038/s12276-024-01177-3 | Review; human transcriptome / RNA regulation | Review of inverted Alu repeats notes neuron-enriched ELAVL2/3/4 in the context of RNA structure and post-transcriptional control, relevant to ELAVL3βs role in neuronal transcriptome regulation and dsRNA-linked processes. | No ELAVL3-specific quantitative value extracted from available excerpt. | (OpenTargets Search: -ELAVL3) |
Table: This table compiles the main 2023-2024 and closest relevant studies in the evidence set that mention ELAVL3/HuC, emphasizing function, disease relevance, and quantitative findings. It is useful as a quick reference for prioritizing the strongest sources for functional annotation and clinical context.
A 2023 synthesis of molecular genetics evidence highlights that ELAVL3 loss perturbs alternative splicing programs converging on glutamate regulation and neuronal excitability; for example, ELAVL3 regulates developmental splicing of a vertebrate-specific exon in ANK3/AnkyrinG (AnkG exon 34), where knockout animals show inappropriate exon inclusion at later ages (reported at 2 and 9 months) and human RNA-seq supports canonical exon exclusion in human prefrontal cortex. These findings connect ELAVL3βs molecular splicing control to circuit-level phenotypes such as seizures/ataxia observed in model systems. (mulligan2023themoleculargenetics pages 6-7)
Multiple lines of evidence link neuronal ELAVL proteins to APA and neuronal 3β²UTR lengthening. During differentiation toward inhibitory neuronal fates, ELAVL3 expression increases alongside 3β²UTR lengthening, and ELAVL3 depletion shifts poly(A) usage toward proximal sites and delays differentiation. (mulligan2023themoleculargenetics pages 6-7)
A 2023 Science Immunology study provided a mechanistic framework in human cellular systems: co-expression of neuron-enriched ELAVL proteins (HuB/HuC/HuD; ELAVL2/3/4) can produce global 3β²UTR lengthening (isoform switching without major changes in total transcript abundance), which increases the formation of immunostimulatory dsRNA structures and engages dsRNA sensors (MDA5, PKR, TLR3). This work places ELAVL-family-mediated 3β²UTR regulation upstream of innate immune tone in neurons and provides an emerging functional link between neuronal post-transcriptional programs and neuroinflammatory risk. (dorrity2023long3β²utrspredispose pages 8-9)
A recent review of ELAV/Hu proteins notes CLIP-based evidence that ELAVL3 binds U-rich regions in glutamine synthetase mRNA and highlights connections to glutamate-network regulation and electrical activity. While this is review-level synthesis (and not 2023β2024), it provides a pathway-level interpretation consistent with the 2023 genetics review emphasis on excitability/glutamate-related targets. (wutikeli2025elavhurnabindingprotein pages 6-7, mulligan2023themoleculargenetics pages 6-7)
ELAVL3/HuC is one of the neuronal ELAVL proteins that constitute the anti-Hu (nELAVL) autoantigen family in paraneoplastic neurological disorders. A proteome-wide programmable phage display (PhIP-seq) study of anti-Hu patients demonstrates real-world translational use of epitope mapping for diagnosis/biomarker characterization, identifying a focused signature and an immunodominant motif shared across nELAVLs. (oβdonovan2020highresolutionepitopemapping pages 1-2, oβdonovan2020highresolutionepitopemapping pages 2-3)
Key cohort-level statistics from this study include: anti-Hu cohort n=44, with 38% showing enrichment for nELAVL peptides; anti-Yo comparator cohort n=36; and 0/50 healthy control sera showing significant nELAVL peptide enrichment in this assay. (oβdonovan2020highresolutionepitopemapping pages 1-2, oβdonovan2020highresolutionepitopemapping pages 10-10)
The epitope-level resolution is supported by figure evidence showing cohort mapping and the sequence-logo motif: (oβdonovan2020highresolutionepitopemapping media bbad15e1, oβdonovan2020highresolutionepitopemapping media f77dc5fb)
A 2024 human neuropathology-focused work reports nuclear depletion of ELAVL3 in ALS/FTLD-spectrum disease tissue, including a prior finding that nearly 75% of anterior horn motor neurons showed total loss of nuclear ELAVL3. In cortex, reduced nuclear ELAVL3 is associated with cells containing phosphorylated aggregates (TDP-43 or tau), with overlap in FTLD-tau cases (majority 4/5 showing related ELAVL3 nuclear loss in cells with phosphorylated aggregates). These observations motivate ELAVL3 immunostaining/localization as a practical research readout and candidate biomarker feature across proteinopathies. (costantino2024elavl3disruptionina pages 107-112, costantino2024elavl3disruptioninb pages 107-112)
A 2023 European Journal of Human Genetics review frames nELAVL proteins (including ELAVL3/HuC) as central organizers of neuronal post-transcriptional programs across developmental windows, emphasizing the integration of splicing, APA/3β²UTR length, and mRNA stability/translation in shaping neuronal identity and function. This review also highlights that ELAVL-related pathology shares a neurological theme but with phenotype specificity across paralogs, consistent with their spatiotemporal expression differences. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 6-7)
The 2023 Science Immunology study provides an expert-level mechanistic reframing: neuron-specific post-transcriptional choices (e.g., longer 3β²UTRs) are not only developmental/regulatory features but can become immunostimulatory substrates (dsRNA) that set baseline antiviral signaling and potentially contribute to toxic inflammation if dysregulated (e.g., in ADAR1 deficiency). This suggests ELAVL-family RBPs may influence neuroinflammation risk indirectly through transcript architecture rather than classical cytokine pathways. (dorrity2023long3β²utrspredispose pages 8-9)
| Context | Finding | Quantitative/statistics | Application/implementation | Supporting citation IDs |
|---|---|---|---|---|
| Paraneoplastic anti-Hu autoimmunity cohort | Anti-Hu paraneoplastic neurological disorder sera/CSF show reactivity to neuronal ELAVL proteins (including ELAVL3/HuC), but the dominant mapped response in this dataset is concentrated on shared nELAVL epitopes and is largely ELAVL4-biased rather than ELAVL3-specific. | Anti-Hu cohort n=44; anti-Yo comparator n=36; 38% of anti-Hu patients enriched nELAVL peptides; 76 anti-Hu samples total (32 paired serum/CSF, 2 CSF, 10 serum); 19 samples with significant nELAVL enrichment; 20 unique nELAVL peptides; >80% of enriched peptides mapped to ELAVL4; 0/50 healthy control sera showed significant nELAVL enrichment. | Supports laboratory use of PhIP-Seq/high-resolution epitope mapping for paraneoplastic antibody characterization and differential diagnosis; high control specificity in this dataset supports translational diagnostic value. | (oβdonovan2020highresolutionepitopemapping pages 2-3, oβdonovan2020highresolutionepitopemapping pages 10-10, oβdonovan2020highresolutionepitopemapping pages 1-2) |
| Anti-Hu epitope definition | The immunodominant anti-Hu/nELAVL antibody signature maps to a short region near the exon 6/7a junction and centers on a recurring motif shared across nELAVL proteins, including ELAVL3. | Dominant 17-residue signature; deep mutational scanning identified a preferred RLDxLL motif; 34/36 (94%) significant peptides in motif reanalysis shared RLDxxLL. | Enables epitope-level assay design, mechanistic interpretation of anti-Hu serology, and refined antigen mapping beyond whole-protein tests. | (oβdonovan2020highresolutionepitopemapping pages 2-3, oβdonovan2020highresolutionepitopemapping pages 13-13, oβdonovan2020highresolutionepitopemapping pages 13-14, oβdonovan2020highresolutionepitopemapping media bbad15e1, oβdonovan2020highresolutionepitopemapping media f77dc5fb) |
| Central tolerance / antigenicity context | The anti-Hu signature region is linked to thymic exon exclusion and predicted MHC-I presentation, consistent with a mechanism for autoreactivity against nELAVL proteins. | In human thymic epithelial cell amplicon sequencing, exon 7a-containing reads were <0.5%; human TEC libraries averaged ~1 million 125-nt paired-end reads each, in triplicate. | Relevant to mechanistic interpretation of paraneoplastic autoimmunity and may guide future biomarker/epitope validation studies. | (oβdonovan2020highresolutionepitopemapping pages 13-13, oβdonovan2020highresolutionepitopemapping pages 13-14) |
| ALS/FTLD neuropathology | Human neurodegenerative disease tissue shows ELAVL3/HuC nuclear depletion and abnormal cytoplasmic pathology, supporting ELAVL3 disruption as a neuropathological marker in ALS/FTLD-spectrum disease. | Prior anterior horn motor neuron study: nearly 75% of neurons showed total loss of nuclear ELAVL3. | Potential neuropathology biomarker and disease-stratification feature in ALS/FTLD research workflows; supports ELAVL3 immunostaining as a readout of RNA-binding protein dysfunction. | (costantino2024elavl3disruptioninb pages 107-112, costantino2024elavl3disruptionina pages 107-112, mulligan2023themoleculargenetics pages 5-6) |
| FTLD-Tau overlap | ELAVL3 nuclear loss is not restricted to TDP-43 proteinopathy and also appears in tauopathy-associated FTLD cells with phosphorylated aggregates. | Majority of FTLD-Tau cases 4/5 showed related ELAVL3 nuclear loss in cells with phosphorylated aggregates. | Suggests ELAVL3 depletion may be a shared marker across proteinopathies, broadening relevance beyond classic TDP-43 ALS/FTLD. | (costantino2024elavl3disruptioninb pages 107-112, costantino2024elavl3disruptionina pages 107-112) |
| Human ALS model relevance | ELAVL3 abnormalities may occur early in disease-linked cellular models and have been proposed as earlier or complementary markers relative to TDP-43 abnormalities. | Review-level summary indicates ELAVL3 abnormalities were reported as more common/earlier than TDP-43 abnormalities in cited patient/model studies, but no explicit n or effect size was provided in the extracted text. | Supports investigation of ELAVL3 as an early biomarker or therapeutic focus in ALS research, though quantitative validation is still needed. | (mulligan2023themoleculargenetics pages 5-6) |
| Open Targets disease association | ELAVL3 has curated disease-target associations in Open Targets spanning neurodevelopmental and neurologic phenotypes. | Neurodegenerative disease score 0.4831; Cannabis use 0.1452; generalised epilepsy 0.0978; autism spectrum disorder 0.0924; generalized epilepsy with febrile seizures-plus 0.0874; evidence count 5 for each listed disease in the retrieved summary. | Useful for target prioritization, disease landscaping, and hypothesis generation; these are association scores, not proof of causality. | (OpenTargets Search: -ELAVL3) |
Table: This table summarizes clinically relevant ELAVL3/HuC evidence from the retrieved literature and databases, including anti-Hu paraneoplastic autoimmunity metrics, neuropathology findings in ALS/FTLD, and Open Targets disease associations. It is useful for connecting molecular annotation to diagnostic and translational contexts.
Additional notable quantitative points include:
- In anti-Hu PhIP-seq epitope mapping, the immunodominant motif was highly recurrent: 34/36 (94%) significant peptides shared an RLDxxLL core, supporting a dominant motif-level signature across enriched peptides. (oβdonovan2020highresolutionepitopemapping pages 13-13)
- Thymic epithelial cell sequencing found exon 7a-containing reads at <0.5%, offering a quantitative clue about central tolerance mechanisms for the anti-Hu signature region. (oβdonovan2020highresolutionepitopemapping pages 13-14)
- A 2024 integrative single-cell atlas of developing human brain compiled 393,060 single cells, providing modern context for neuronal lineage markers and disorder-gene temporal specificity (including ELAVL3). (OpenTargets Search: -ELAVL3)
ELAVL3 expression and function are tied to neuronal differentiation programs, including inhibitory neuron differentiation in model systems, where ELAVL3 depletion delays differentiation and shifts APA toward proximal sites. (mulligan2023themoleculargenetics pages 6-7)
Genetic and molecular data converge on ELAVL3-dependent regulation of transcripts linked to glutamate regulation and neuronal excitability, consistent with seizure phenotypes in loss-of-function contexts and with CLIP-based linking to glutamine synthetase mRNA described in review synthesis. (mulligan2023themoleculargenetics pages 6-7, wutikeli2025elavhurnabindingprotein pages 6-7)
Neuron-enriched ELAVL proteins (including HuC/ELAVL3) can drive longer 3β²UTRs and increased dsRNA structures that activate dsRNA-sensing PRRs (MDA5, PKR, TLR3), tying ELAVL-family activity to innate immune tone and vulnerability/resilience to neurotropic viral infection or toxic inflammation under editing defects. (dorrity2023long3β²utrspredispose pages 8-9)
Although ELAVL3 is well supported as an RBP controlling splicing/APA/stability and linked to excitability and disease phenotypes, the retrieved 2023β2024 primary literature in this run provides limited direct, ELAVL3-only quantitative biochemistry (e.g., binding affinities, target lists) compared with the broader nELAVL family; several mechanistic target statements are presented via reviews. (mulligan2023themoleculargenetics pages 6-7, wutikeli2025elavhurnabindingprotein pages 6-7)
References
(mulligan2023themoleculargenetics pages 1-2): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.
(mulligan2023themoleculargenetics pages 2-4): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.
(negeri2024theroleof pages 39-45): Olanta Negeri. The role of the elavl family of rna-binding proteins in lrrk2-dependent models of parkinson's disease. Text, Feb 2024. URL: https://doi.org/10.20381/ruor-30139, doi:10.20381/ruor-30139. This article has 0 citations and is from a peer-reviewed journal.
(medici2026targetingtherna pages 8-12): M Medici. Targeting the rna binding protein hud to control als disease. Unknown journal, 2026.
(mulligan2023themoleculargenetics pages 7-8): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.
(costantino2024elavl3disruptionina pages 22-26): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.
(costantino2024elavl3disruptionin pages 22-26): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.
(mulligan2023themoleculargenetics pages 6-7): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.
(dorrity2023long3β²utrspredispose pages 8-9): Tyler J. Dorrity, Heegwon Shin, Kenenni A. Wiegand, Justin Aruda, Michael Closser, Emily Jung, Jake A. Gertie, Amanda Leone, Rachel Polfer, Bruce Culbertson, Lisa Yu, Christine Wu, Takamasa Ito, Yuefeng Huang, Anna-Lena Steckelberg, Hynek Wichterle, and Hachung Chung. Long 3β²utrs predispose neurons to inflammation by promoting immunostimulatory double-stranded rna formation. Science Immunology, Oct 2023. URL: https://doi.org/10.1126/sciimmunol.adg2979, doi:10.1126/sciimmunol.adg2979. This article has 65 citations and is from a highest quality peer-reviewed journal.
(wutikeli2025elavhurnabindingprotein pages 6-7): Huxitaer Wutikeli, Ting Xie, Wenjun Xiong, and Yin Shen. Elav/hu rna-binding protein family: key regulators in neurological disorders, cancer, and other diseases. RNA Biology, 22:1-11, Feb 2025. URL: https://doi.org/10.1080/15476286.2025.2471133, doi:10.1080/15476286.2025.2471133. This article has 21 citations and is from a peer-reviewed journal.
(mulligan2023themoleculargenetics pages 4-5): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.
(mulligan2023themoleculargenetics pages 5-6): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping pages 2-3): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping pages 13-13): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping pages 10-10): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping pages 1-2): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping pages 13-14): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping pages 12-13): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping media bbad15e1): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(oβdonovan2020highresolutionepitopemapping media f77dc5fb): Brian OβDonovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.
(costantino2024elavl3disruptioninb pages 107-112): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.
(costantino2024elavl3disruptionina pages 107-112): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.
(costantino2024elavl3disruptionina pages 1-7): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.
(OpenTargets Search: -ELAVL3): Open Targets Query (-ELAVL3, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
ELAVL3 (ELAV-like RNA Binding Protein 3) is a neuron-specific RNA-binding protein in humans, playing a critical role in post-transcriptional gene regulation within the central nervous system. It is essential for neuronal differentiation, maintenance, and synaptic integrity[1][3][5].
Molecular Function:
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3β²-untranslated regions (3β²-UTRs) of target pre-mRNAs[1][3]. This binding regulates alternative splicing, mRNA stability, and transcript abundance, especially for genes involved in glutamate synthesis and neuronal excitability[1][3][5].
Protein Domains:
ELAVL3 contains three RNP-type RNA recognition motifs (RRMs), which are responsible for its RNA-binding activity[1][3][10].
RRM1, RRM2, RRM3: These domains mediate binding to AU-rich elements and poly-A tracts in mRNAs[3][10].
Biological Processes:
Cerebellar cell differentiation and maintenance: Highly expressed in Purkinje cells and hippocampus, indicating a role in cerebellar structure[2][5].
Cellular Localization:
ELAVL3 is predominantly localized in the nucleus and cytoplasm of neurons throughout the brain, including the cerebral cortex, hippocampus, cerebellum (especially Purkinje cells), and other regions[2][5][7][10].
Neuroendocrine Cancer:
ELAVL3 is essential for the development and maintenance of neuroendocrine prostate cancer. RIP-seq analysis identified over 1,100 transcripts bound by ELAVL3, many related to neuronal and RNA-specific processes[4] (Nature Communications, 2023).
Brain Development and Disease:
Recent reviews highlight ELAVL3βs role in brain development and its dysregulation in neurological diseases, including neurodegenerative disorders and paraneoplastic syndromes[6] (European Journal of Human Genetics, 2023).
Disease Biomarker:
ELAVL3 is recognized as a Hu antigen and is targeted by anti-Hu antibodies in patients with paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN), making it a diagnostic marker for these autoimmune neurological disorders[1][3].
Therapeutic Target:
The ELAVL3/MYCN positive feedback loop has been identified as a potential therapeutic target in neuroendocrine prostate cancer[4].
Neuronal Health:
Disruption of ELAVL3 leads to aberrant splicing events, altered mRNA levels, and compromised glutamate homeostasis, resulting in hyperexcitability and spontaneous seizure activity[1][5].
Neurodegeneration:
ELAVL3 knockout mice exhibit progressive motor deficits, severe cerebellar ataxia, and Purkinje cell axonal degeneration, linking ELAVL3 dysfunction to neurodegenerative processes such as spinocerebellar ataxia[5].
Functional Associations:
ELAVL3 has 5,995 functional associations with biological entities across 8 categories, including molecular profile, disease, phenotype, and structural features, extracted from 90 datasets[1].
Transcriptome Binding:
In neuroendocrine cancer cell lines, ELAVL3 binds over 1,100 transcripts, with enrichment for genes involved in neuron projection development and synapse organization[4].
RNA Targets:
ELAVL3 binds to mRNAs with AU-rich elements, including VEGF mRNA and GAP43 mRNA, stabilizing these transcripts and influencing spatial learning and neuronal maintenance[3][10].
Protein Interactions:
ELAVL3 interacts with other ELAVL family members (e.g., ELAVL4) and proteins involved in RNA processing and neuronal differentiation[3][10].
Paraneoplastic Neurological Syndromes:
ELAVL3 is a target of anti-Hu antibodies in paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN)[1][3].
Neurodegenerative Diseases:
Associations have been reported between ELAVL3 dysfunction and spinocerebellar ataxia, as well as other neurodegenerative conditions characterized by Purkinje cell loss and cerebellar atrophy[5][6].
Sensory Peripheral Neuropathy and Limbic Encephalitis:
ELAVL3 is linked to these diseases through its role as a Hu antigen and its involvement in neuronal maintenance[3].
| Feature | Details | Source(s) |
|---|---|---|
| Molecular Function | RNA-binding (GU-rich, AU-rich), mRNA splicing/stability, glutamate regulation | [1][3][10] |
| Protein Domains | 3 RNP-type RNA recognition motifs (RRM1, RRM2, RRM3) | [1][3][10] |
| Biological Process | Neurogenesis, synapse organization, neuron projection, cerebellar maintenance | [1][2][4][5] |
| Cellular Localization | Nucleus and cytoplasm of neurons (cortex, hippocampus, cerebellum, Purkinje cells) | [2][5][7][10] |
| Known Interactions | mRNAs (VEGF, GAP43), ELAVL family proteins | [3][10] |
| Disease Associations | Paraneoplastic syndromes, spinocerebellar ataxia, neuroendocrine cancer, neuropathy | [1][3][4][5][6] |
Key References:
- [Ma'ayan Lab Harmonizome, 2024][1]
- [RNA Biology, 2025][2]
- [GeneCards, 2024][3]
- [Nature Communications, 2023][4]
- [Scientific Reports, 2018][5]
- [Protein Atlas, 2024][7]
- [UniProt, 2024][10]
URLs and Publication Dates:
- Ma'ayan Lab Harmonizome: https://maayanlab.cloud/Harmonizome/gene/ELAVL3 (2024)
- RNA Biology: https://pmc.ncbi.nlm.nih.gov/articles/PMC11926907/ (2025)
- GeneCards: https://www.genecards.org/cgi-bin/carddisp.pl?gene=ELAVL3 (2024)
- Nature Communications: https://www.nature.com/articles/s41598-018-21130-5 (2018)
- Protein Atlas: https://www.proteinatlas.org/ENSG00000196361-ELAVL3 (2024)
- UniProt: https://www.uniprot.org/uniprotkb/Q14576/entry (2024)
If you require more detailed data on specific protein interactions or transcriptome-wide binding profiles, recent high-throughput studies (RIP-seq, CLIP-seq) provide comprehensive lists of ELAVL3 targets in neuronal and cancer contexts[4][8].
Completed systematic review of all existing GO annotations for human ELAVL3 (HuC), a neuron-specific RNA-binding protein.
ELAVL3 (HuC) is a neuron-specific RNA-binding protein with three RNA recognition motifs (RRMs) that binds to AU-rich elements in the 3'-UTRs of target mRNAs to regulate mRNA stability, alternative splicing, and transcript abundance. It plays essential roles in neuronal differentiation, maintenance, and synaptic integrity, particularly in the cerebellum and hippocampus.
Core molecular function representing ELAVL3's role as an adaptor between RNA and regulatory machinery
GO:0003723 (RNA binding) - IEA
General but accurate molecular function term
GO:0003730 (mRNA 3'-UTR binding) - IEA
Specific and accurate molecular function
GO:0007399 (nervous system development) - IEA
Well-supported biological process
GO:1990904 (ribonucleoprotein complex) - IEA
Appropriate cellular component
GO:0035925 (mRNA 3'-UTR AU-rich region binding) - IEA
Most specific molecular function term
GO:0035925 (mRNA 3'-UTR AU-rich region binding) - IDA (PMID:10710437)
Too broad; ELAVL3 specifically binds RNA, not DNA
GO:0030154 (cell differentiation) β GO:0030182 (neuron differentiation)
Generic uninformative term from large-scale proteomics study
GO:0005515 (protein binding) - IPI (PMID:37207277)
Binds to AU-rich elements in the 3'-UTRs of target mRNAs to regulate their stability, alternative splicing, and abundance, particularly for genes involved in neuronal function and glutamate synthesis.
Key Evidence:
- Direct experimental evidence (PMID:10710437) showing HuC binding to VEGF and c-myc 3'-UTRs
- IBA annotation supporting protein-RNA adaptor activity
- Involvement in nervous system development and neuron differentiation
Forms ribonucleoprotein complexes in both nucleus and cytoplasm of neurons.
β File validates successfully with no errors
- Status: COMPLETE
- All 11 annotations reviewed and actioned
- Core functions defined with supporting evidence
id: Q14576
gene_symbol: ELAVL3
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: ELAVL3 (HuC) is a neuron-specific RNA-binding protein with three RNA
recognition motifs (RRMs) and a hinge/linker region that binds to AU-/U-rich elements
in the 3'-UTRs of target mRNAs to regulate mRNA stability, alternative splicing,
alternative polyadenylation (3'-UTR length choice), and transcript abundance. RRM1
and RRM2 directly associate with AU-rich RNA, while RRM3 promotes transcript stability
via poly(A)-tail-associated mechanisms. ELAVL3 is predominantly cytoplasmic but
shuttles between nucleus and cytoplasm via signals in the hinge region. It plays
essential roles in neuronal differentiation, maintenance, and synaptic integrity,
particularly in the cerebellum and hippocampus; ELAVL3 loss perturbs splicing programs
converging on glutamate regulation and neuronal excitability (e.g., AnkG exon 34
mis-inclusion), producing seizures and cerebellar ataxia in knockout models.
existing_annotations:
- term:
id: GO:0140517
label: protein-RNA adaptor activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: IBA annotation for protein-RNA adaptor activity based on phylogenetic
inference. ELAVL3 functions as an RNA-binding protein that binds AU-rich elements
in 3'-UTRs and regulates mRNA stability and processing, consistent with adaptor
activity.
action: ACCEPT
reason: This term accurately captures ELAVL3's core molecular function as a protein
that mediates interactions between RNA molecules and other cellular components
through its RNA-binding activity. The deep research confirms ELAVL3 "binds preferentially
to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions
(3'-UTRs) of target pre-mRNAs" and "regulates alternative splicing, mRNA stability,
and transcript abundance". UniProt confirms it "binds to AU-rich element (ARE)
sequences of target mRNAs" [PMID:10710437]. IBA annotations are typically well-curated
and phylogenetically sound.
supported_by:
- reference_id: PMID:10710437
supporting_text: HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS)
and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs.
This binding regulates alternative splicing, mRNA stability, and transcript
abundance
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
supporting_text: ELAVL3 functions primarily as a post-transcriptional regulator
that stabilizes target transcripts, in part by binding AU-rich elements and
influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize
on RNA and oppose destabilizing factors.
- reference_id: PMID:37697079
supporting_text: Binding to RNA targets is facilitated by the RRM1 and RRM2
domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
- term:
id: GO:0003676
label: nucleic acid binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: IEA annotation for nucleic acid binding based on InterPro domain assignment.
This is a very general parent term for RNA binding.
action: MODIFY
reason: While technically correct (ELAVL3 does bind nucleic acids), this term
is too broad and uninformative. ELAVL3 specifically binds RNA, not DNA, through
its three RRM domains. The more specific term GO:0003723 (RNA binding) is already
annotated and better represents the actual molecular function.
proposed_replacement_terms:
- id: GO:0003723
label: RNA binding
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 contains three RNP-type RNA recognition motifs (RRMs),
which are responsible for its RNA-binding activity
- term:
id: GO:0003723
label: RNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: IEA annotation for RNA binding from combined automated annotation methods.
This is appropriate but less specific than the available AU-rich region binding
terms.
action: ACCEPT
reason: This term accurately describes ELAVL3's core molecular function. ELAVL3
contains three RRM domains that bind RNA, specifically to AU-rich and GU-rich
sequences in mRNA 3'-UTRs. While more specific terms exist (mRNA 3'-UTR AU-rich
region binding), this general RNA binding term is acceptable and correct as
a broader classification.
supported_by:
- reference_id: PMID:10710437
supporting_text: These proteins bind to AU-rich elements in the 3'-untranslated
regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 contains three RNP-type RNA recognition motifs (RRMs),
which are responsible for its RNA-binding activity
- reference_id: PMID:37697079
supporting_text: All four ELAVL proteins share a common basic structure, of
three RNA recognition motif (RRM) binding domains and a hinge region
- term:
id: GO:0003730
label: mRNA 3'-UTR binding
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: IEA annotation for mRNA 3'-UTR binding from ARBA machine learning models.
This accurately captures ELAVL3's specific binding preference for 3'-UTR regions.
action: ACCEPT
reason: This is a highly specific and accurate molecular function term for ELAVL3.
Multiple lines of evidence demonstrate that ELAVL3 preferentially binds to AU-rich
elements located in the 3'-UTRs of target mRNAs including VEGF and c-myc. This
is a core molecular function of the protein.
supported_by:
- reference_id: PMID:10710437
supporting_text: HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS)
and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
- term:
id: GO:0007399
label: nervous system development
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: IEA annotation for nervous system development based on UniProtKB keyword
mapping. ELAVL3 is neuron-specific and plays roles in neuronal differentiation
and maintenance.
action: ACCEPT
reason: This biological process term is well-supported. ELAVL3 is brain-specific
and essential for neurogenesis, neuronal differentiation, and maintenance of
neurons. The deep research indicates ELAVL3 is "involved in the development
and maintenance of neurons" and knockout mice exhibit severe motor deficits
and cerebellar ataxia. UniProt states it "may be involved in neuronal differentiation
and maintenance".
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: 'Neurogenesis: ELAVL3 is involved in the development and maintenance
of neurons'
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 knockout mice exhibit progressive motor deficits, severe
cerebellar ataxia, and Purkinje cell axonal degeneration
- reference_id: PMID:37697079
supporting_text: As Elavl3β/β mice aged, progressive severe cerebellar ataxia
was observed
- reference_id: PMID:37697079
supporting_text: At the cellular level, Purkinje neurons had disrupted synaptic
formation, swollen axons, and overall deficits in neuronal transport, highlighting
the requirement for Elavl3 activity in these neurons
- term:
id: GO:0030154
label: cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: IEA annotation for cell differentiation based on UniProtKB keyword mapping.
This is a very general process term that applies to ELAVL3's role in neuronal
differentiation.
action: MODIFY
reason: While technically correct (ELAVL3 is involved in neuronal differentiation),
this term is too broad and non-specific. The more precise term would be neuronal
differentiation or neuron differentiation, which better captures ELAVL3's tissue-specific
role. Given that ELAVL3 is brain-specific and specifically involved in neurogenesis,
a more specific term should be used.
proposed_replacement_terms:
- id: GO:0030182
label: neuron differentiation
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: 'Neurogenesis: ELAVL3 is involved in the development and maintenance
of neurons'
- reference_id: PMID:37697079
supporting_text: Elavl3 expression is upregulated during the differentiation
of neural stem cells into inhibitory GABAergic neurons, in parallel with 3βUTR
lengthening. Depletion of Elavl3 during this differentiation process caused
a shift towards using proximal polyA sites compared to control cells, with
a concomitant delay in neural stem cell differentiation
- term:
id: GO:1990904
label: ribonucleoprotein complex
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: IEA annotation for ribonucleoprotein complex based on InterPro domain
assignment. This cellular component term reflects ELAVL3's association with
RNA as an RNP complex component.
action: ACCEPT
reason: This is an appropriate cellular component annotation. ELAVL3 is an RNA-binding
protein with RRM domains that forms ribonucleoprotein complexes with its target
mRNAs. The deep research notes ELAVL3 binds over 1,100 transcripts in certain
contexts, indicating it forms functional RNP complexes. While more specific
localization terms could be added (nucleus, cytoplasm), this general RNP complex
annotation is correct.
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: In neuroendocrine cancer cell lines, ELAVL3 binds over 1,100
transcripts, with enrichment for genes involved in neuron projection development
and synapse organization
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 is predominantly localized in the nucleus and cytoplasm
of neurons throughout the brain
- term:
id: GO:0035925
label: mRNA 3'-UTR AU-rich region binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for mRNA 3'-UTR AU-rich region binding from Ensembl Compara
orthology transfer. This is the most specific and accurate molecular function
term for ELAVL3.
action: ACCEPT
reason: This is the most precise molecular function annotation for ELAVL3 and
represents its core biochemical activity. ELAVL3 specifically binds to AU-rich
elements (AREs) in the 3'-UTRs of target mRNAs. PMID:10710437 experimentally
demonstrates HuC binding to AU-rich regions in VEGF and c-myc 3'-UTRs. The deep
research confirms binding to "GU-rich and AU-rich sequences" in 3'-UTRs. This
annotation captures the key sequence specificity that distinguishes ELAVL3 from
general RNA-binding proteins.
supported_by:
- reference_id: PMID:10710437
supporting_text: These proteins bind to AU-rich elements in the 3'-untranslated
regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:36950384
review:
summary: IPI annotation for protein binding based on physical interaction evidence
from a large-scale proteomics study on autism spectrum disorders.
action: REMOVE
reason: While ELAVL3 does interact with proteins (UniProt mentions MAP1B light
chain LC1, and IntAct shows interactions with DYRK1A, SCN2A, SYNGAP1), the generic
"protein binding" term is uninformative and does not describe a molecular function.
This term should not be used unless referring to a specific functional role
(e.g., as an adapter or scaffold). The reference PMID:36950384 is a large-scale
protein interaction study where ELAVL3 may have been detected as an interactor,
but this does not constitute evidence for "protein binding" as a molecular function.
ELAVL3's primary molecular function is RNA binding, not protein binding.
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: "Molecular Function: ELAVL3 binds preferentially to GU-rich\
\ and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs)\
\ of target pre-mRNAs"
- reference_id: PMID:36950384
supporting_text: eCollection 2023 Mar 8.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:37207277
review:
summary: IPI annotation for protein binding based on physical interaction evidence
from a large-scale brain cell-type-specific protein interactome study on schizophrenia.
action: REMOVE
reason: Same rationale as for PMID:36950384. The generic "protein binding" term
is uninformative and should be avoided in GO curation. While ELAVL3 does engage
in protein-protein interactions, this is not its primary molecular function,
and the term does not provide useful functional information. ELAVL3 is fundamentally
an RNA-binding protein. Large-scale proteomics studies detect many interactions,
but these do not necessarily represent the core molecular function of the protein.
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: "Molecular Function: ELAVL3 binds preferentially to GU-rich\
\ and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs)\
\ of target pre-mRNAs"
- reference_id: PMID:37207277
supporting_text: eCollection 2023 May 19.
- term:
id: GO:0035925
label: mRNA 3'-UTR AU-rich region binding
evidence_type: IDA
original_reference_id: PMID:10710437
review:
summary: IDA annotation for mRNA 3'-UTR AU-rich region binding based on direct
experimental evidence from PMID:10710437. This is a duplicate of the IEA annotation
but with stronger experimental evidence.
action: ACCEPT
reason: This is the gold standard annotation for ELAVL3 - direct experimental
evidence (IDA) for its most specific and important molecular function. PMID:10710437
directly demonstrates using an ELISA-based assay that HuC (ELAVL3) binds to
AU-rich elements in the 3'-UTRs of VEGF and c-myc mRNAs in a specific and concentration-dependent
manner. This represents the core biochemical activity of ELAVL3. The experimental
evidence is robust and the term is maximally informative.
supported_by:
- reference_id: PMID:10710437
supporting_text: I demonstrate that HuC and HuD bind to the VEGF 3'-UTR regulatory
segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent
pattern
- reference_id: PMID:10710437
supporting_text: These proteins bind to AU-rich elements in the 3'-untranslated
regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
- term:
id: GO:0005634
label: nucleus
evidence_type: NAS
review:
summary: Added to align core_functions with existing annotations.
action: NEW
reason: Core function term not present in existing_annotations. ELAVL3 has a smaller
nuclear pool that supports roles in splicing and APA, consistent with nucleocytoplasmic
shuttling driven by hinge-region signals.
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
enrichment for genes involved in neuron projection development and synapse
organization
- reference_id: UniProtKB:Q14576
supporting_text: May be involved in neuronal differentiation and maintenance
(By similarity).
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
supporting_text: ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic
shuttling. A smaller nuclear pool supports roles in splicing and RNA processing,
while the hinge/linker region contributes to export/localization control.
- reference_id: PMID:37697079
supporting_text: Nuclear export and localisation signals located in the hinge
region of the ELAVL proteins are responsible for the shuttling of RNAs between
the nucleus and cytoplasm
- term:
id: GO:0005737
label: cytoplasm
evidence_type: NAS
review:
summary: Added to align core_functions with existing annotations.
action: NEW
reason: Core function term not present in existing_annotations. nELAVL proteins
including ELAVL3 are predominantly cytoplasmic where they participate in cytoplasmic
mRNA stability and translation control.
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
enrichment for genes involved in neuron projection development and synapse
organization
- reference_id: UniProtKB:Q14576
supporting_text: May be involved in neuronal differentiation and maintenance
(By similarity).
- reference_id: PMID:37697079
supporting_text: nELAVL proteins are primarily cytoplasmic, with a small fraction
of nuclear activity, reflecting their roles (for example nuclear export, subcellular
shuttling)
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
supporting_text: ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic
shuttling.
- term:
id: GO:0010608
label: post-transcriptional regulation of gene expression
evidence_type: NAS
review:
summary: Added to align core_functions with existing annotations.
action: NEW
reason: Core function term not present in existing_annotations. Falcon-cited literature
reinforces ELAVL3's role as a post-transcriptional regulator controlling splicing,
APA/3'-UTR length choice, mRNA stability and translation.
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
enrichment for genes involved in neuron projection development and synapse
organization
- reference_id: UniProtKB:Q14576
supporting_text: May be involved in neuronal differentiation and maintenance
(By similarity).
- reference_id: PMID:37697079
supporting_text: RNA-binding proteins (RBPs) are recognised as key regulators
of post-transcriptional gene regulation, where their binding controls splicing,
polyadenylation, nuclear export, mRNA stability and translation rate and decay
- term:
id: GO:0000380
label: alternative mRNA splicing, via spliceosome
evidence_type: NAS
review:
summary: Added based on falcon-cited literature documenting ELAVL3 regulation
of neuronal alternative splicing programs.
action: NEW
reason: Falcon and Mulligan 2023 (PMID:37697079) document that ELAVL3 regulates
alternative splicing of neuronal transcripts (e.g., AnkG/ANK3 exon 34) with
convergence on glutamate-regulation and excitability pathways. This is a core
molecular process not previously captured in existing_annotations.
supported_by:
- reference_id: PMID:37697079
supporting_text: Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific
exon 34 in the AnkG transcript.
- reference_id: PMID:37697079
supporting_text: High-throughput sequencing analysis of alternative splicing
in the cerebellum of Elavl3β/β mice highlighted the convergence of targeted
transcripts on glutamate levels and neuronal excitability
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
supporting_text: ELAVL3 has a documented role in alternative splicing; all three
RRMs plus the hinge region contribute to HuC-dependent splice regulation,
and ELAVL3 loss alters neuronal splicing programs linked to excitability.
- term:
id: GO:0110104
label: mRNA alternative polyadenylation
evidence_type: NAS
review:
summary: Added based on falcon-cited literature documenting ELAVL3 regulation
of alternative polyadenylation and 3'-UTR length choice in neurons.
action: NEW
reason: Multiple sources cited by falcon (Mulligan 2023 PMID:37697079; Dorrity
2023 PMID:37862432) demonstrate that ELAVL3 (with other nELAVLs) promotes neuronal
3'-UTR lengthening through distal poly(A) site usage; ELAVL3 depletion shifts
usage toward proximal sites. This is a distinct molecular process from splicing/stability
and warrants a separate annotation.
supported_by:
- reference_id: PMID:37697079
supporting_text: Depletion of Elavl3 during this differentiation process caused
a shift towards using proximal polyA sites compared to control cells, with
a concomitant delay in neural stem cell differentiation
- reference_id: PMID:37862432
supporting_text: the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3,
and ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation
of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
supporting_text: ELAVL3 participates in regulation of alternative polyadenylation
and 3β²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal
poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β²UTRs.
- term:
id: GO:0003729
label: mRNA binding
evidence_type: NAS
review:
summary: Added to align core_functions with existing annotations.
action: NEW
reason: Core function term not present in existing_annotations. ELAVL3 binds mRNA
via three RRM domains; this captures the molecular function used to regulate
splicing/APA/stability of target mRNAs.
supported_by:
- reference_id: PMID:37697079
supporting_text: All four ELAVL proteins share a common basic structure, of
three RNA recognition motif (RRM) binding domains and a hinge region
- reference_id: PMID:37697079
supporting_text: Binding to RNA targets is facilitated by the RRM1 and RRM2
domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
# GO:0048167 (regulation of synaptic plasticity) NEW annotation REMOVED
# per PR #684 review feedback. The evidence (disrupted Purkinje neuron
# synaptic formation in Elavl3-/- mice) is an indirect phenotypic
# consequence of losing an RNA-binding regulator, not direct molecular
# evidence that ELAVL3 itself regulates synaptic plasticity. Using a proxy
# GO term because the ideal "regulation of neuronal excitability" term is
# absent is not sound curation practice; moved to proposed_new_terms below.
core_functions:
- description: Binding to AU-rich and GU-rich elements in mRNA 3'-UTRs to stabilize
target transcripts and regulate alternative splicing events in neurons
molecular_function:
id: GO:0035925
label: mRNA 3'-UTR AU-rich region binding
directly_involved_in:
- id: GO:0030182
label: neuron differentiation
- id: GO:0007399
label: nervous system development
- id: GO:0010608
label: post-transcriptional regulation of gene expression
locations:
- id: GO:0005634
label: nucleus
- id: GO:0005737
label: cytoplasm
anatomical_locations:
- id: UBERON:0002129
label: cerebellar cortex
- id: UBERON:0002421
label: hippocampal formation
substrates:
- id: UniProtKB:P15692
label: VEGFA mRNA
- id: UniProtKB:P01106
label: MYC mRNA
- id: UniProtKB:P17677
label: GAP43 mRNA
supported_by:
- reference_id: PMID:10710437
supporting_text: With this assay, I demonstrate that HuC and HuD bind to the VEGF
3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent
pattern, with both proteins showing a greater affinity for the VRS
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs.
This binding regulates alternative splicing, mRNA stability, and transcript
abundance
- reference_id: UniProtKB:Q14576
supporting_text: RNA-binding protein that binds to AU-rich element (ARE) sequences
of target mRNAs, including VEGF mRNA. Plays a role in the stabilization of GAP43
mRNA and in spatial learning
in_complex:
id: GO:1990904
label: ribonucleoprotein complex
- description: Regulating neuronal alternative splicing and alternative polyadenylation/3'-UTR
length choice of target transcripts, including AnkG/ANK3 exon 34 and a broader
program of glutamate-regulating and excitability-related transcripts
molecular_function:
id: GO:0003729
label: mRNA binding
directly_involved_in:
- id: GO:0000380
label: alternative mRNA splicing, via spliceosome
- id: GO:0110104
label: mRNA alternative polyadenylation
- id: GO:0010608
label: post-transcriptional regulation of gene expression
locations:
- id: GO:0005634
label: nucleus
- id: GO:0005737
label: cytoplasm
anatomical_locations:
- id: UBERON:0002129
label: cerebellar cortex
- id: UBERON:0001870
label: frontal cortex
supported_by:
- reference_id: PMID:37697079
supporting_text: Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific
exon 34 in the AnkG transcript.
- reference_id: PMID:37697079
supporting_text: High-throughput sequencing analysis of alternative splicing in
the cerebellum of Elavl3β/β mice highlighted the convergence of targeted transcripts
on glutamate levels and neuronal excitability
- reference_id: PMID:37862432
supporting_text: the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and
ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation
of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
supporting_text: ELAVL3 has a documented role in alternative splicing; all three
RRMs plus the hinge region contribute to HuC-dependent splice regulation, and
ELAVL3 loss alters neuronal splicing programs linked to excitability.
in_complex:
id: GO:1990904
label: ribonucleoprotein complex
- description: Adapting AU-rich mRNA transcripts to post-transcriptional regulatory
complexes to control neuronal gene expression programs
molecular_function:
id: GO:0140517
label: protein-RNA adaptor activity
directly_involved_in:
- id: GO:0030182
label: neuron differentiation
- id: GO:0007399
label: nervous system development
- id: GO:0010608
label: post-transcriptional regulation of gene expression
locations:
- id: GO:0005634
label: nucleus
- id: GO:0005737
label: cytoplasm
anatomical_locations:
- id: UBERON:0002129
label: cerebellar cortex
- id: UBERON:0002421
label: hippocampal formation
supported_by:
- reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
enrichment for genes involved in neuron projection development and synapse organization
- reference_id: UniProtKB:Q14576
supporting_text: May be involved in neuronal differentiation and maintenance.
Plays a role in the stabilization of GAP43 mRNA
in_complex:
id: GO:1990904
label: ribonucleoprotein complex
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara.
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
findings: []
- id: PMID:10710437
title: RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated
regions using a novel ELISA-based assay.
findings: []
- id: PMID:36950384
title: Protein interaction studies in human induced neurons indicate convergent
biology underlying autism spectrum disorders.
findings: []
- id: PMID:37207277
title: Using brain cell-type-specific protein interactomes to interpret neurodevelopmental
genetic signals in schizophrenia.
findings: []
- id: PMID:37697079
title: The molecular genetics of nELAVL in brain development and disease.
findings:
- statement: ELAVL3 is the only nELAVL expressed in Purkinje neurons; Elavl3 knockout
mice develop progressive cerebellar ataxia with disrupted Purkinje synaptic
formation, swollen axons, and neuronal transport deficits, and Elavl3+/- and
-/- mice show seizure activity.
supporting_text: As Elavl3β/β mice aged, progressive severe cerebellar ataxia
was observed. This ataxia caused an abnormal step cycle, tremor and over time,
impaired postural reflexes. At the cellular level, Purkinje neurons had disrupted
synaptic formation, swollen axons, and overall deficits in neuronal transport,
highlighting the requirement for Elavl3 activity in these neurons
reference_section_type: RESULTS
- statement: ELAVL3 regulates alternative splicing of neuronal transcripts converging
on glutamate regulation and excitability, including embryonic-specific inclusion
of AnkG exon 34; ELAVL3 also drives 3'-UTR lengthening via distal poly(A) site
usage during inhibitory neuron differentiation.
supporting_text: High-throughput sequencing analysis of alternative splicing in
the cerebellum of Elavl3β/β mice highlighted the convergence of targeted transcripts
on glutamate levels and neuronal excitabilityβlinking RNA regulation to the
seizure activity observed in Elavl3β/β mice
reference_section_type: RESULTS
- statement: All four ELAVL proteins share three RNA recognition motifs (RRMs)
with a hinge region; RRM1 and RRM2 directly bind AU-rich elements in 3'-UTRs,
while RRM3 supports transcript stability via poly(A)-associated mechanisms.
supporting_text: Binding to RNA targets is facilitated by the RRM1 and RRM2 domains
preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
reference_section_type: LITERATURE_REVIEW
- id: PMID:37862432
title: Long 3'UTRs predispose neurons to inflammation by promoting immunostimulatory
double-stranded RNA formation.
findings:
- statement: The neuron-enriched ELAVL family (ELAVL2, ELAVL3, ELAVL4) collectively
drives 3'-UTR lengthening in human neurons, which in turn raises dsRNA load
and tonically activates dsRNA-sensing PRRs (MDA5, PKR, TLR3).
supporting_text: the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and
ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation
of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
reference_section_type: ABSTRACT
- id: PMID:32954318
title: High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable
phage display.
findings:
- statement: ELAVL3/HuC is one of the neuronal ELAVL (nELAVL) proteins targeted
by anti-Hu paraneoplastic autoantibodies; the dominant immunodominant epitope
maps to a 17-residue motif in the hinge region between RRM2 and RRM3 shared
across ELAVL2/3/4, with most enriched peptides (>80%) attributed to ELAVL4.
supporting_text: A majority (>90%) of the significantly enriched nELAVL peptides
converged upon on a 17-residue sequence at AA positions 276β294 of ELAVL4, a
sequence which is also common to variants of ELAVL2 and ELAVL3
reference_section_type: RESULTS
- id: PMID:40000387
title: ELAV/Hu RNA-binding protein family - key regulators in neurological disorders,
cancer, and other diseases.
findings:
- statement: ELAVL3 is restricted to the nervous system, essential for cerebellar
function, and involved in neuronal differentiation and excitability; ELAVL3
dysregulation is associated with epilepsy.
supporting_text: Both Elavl3 and Elavl4 are restricted to the nervous system and
are involved in neuronal differentiation and excitability. Elavl3 is essential
for cerebellar function and has been associated with epilepsy
reference_section_type: ABSTRACT
- id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
title: 'Falcon (Edison Scientific Literature) deep research report: ELAVL3 (HuC)
functional annotation'
findings:
- statement: ELAVL3 functions as a post-transcriptional regulator that uses three
RRMs plus a hinge region to bind AU-/U-rich elements in 3'-UTRs, with RRM3 contributing
poly(A)-tail binding; functions span splicing, APA/3'-UTR length, mRNA stability,
and translation. ELAVL3 is predominantly cytoplasmic with nucleocytoplasmic
shuttling.
supporting_text: ELAVL3 functions primarily as a post-transcriptional regulator
that stabilizes target transcripts, in part by binding AU-rich elements and
influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize
on RNA and oppose destabilizing factors.
reference_section_type: OTHER
- statement: ELAVL3 has a documented role in alternative splicing in which all three
RRMs plus the hinge region contribute to HuC-dependent splice regulation; ELAVL3
loss alters neuronal splicing programs linked to excitability.
supporting_text: ELAVL3 has a documented role in alternative splicing; all three
RRMs plus the hinge region contribute to HuC-dependent splice regulation, and
ELAVL3 loss alters neuronal splicing programs linked to excitability.
reference_section_type: OTHER
- statement: ELAVL3 participates in alternative polyadenylation control of neuronal
3'-UTR length; ELAVL3 depletion shifts poly(A) usage toward proximal sites.
supporting_text: ELAVL3 participates in regulation of alternative polyadenylation
and 3β²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A)
sites, whereas neuronal ELAVL proteins promote longer neuronal 3β²UTRs.
reference_section_type: OTHER